2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetic acid, 95.0%, 25g

4-Acetyl-1-methyl-1-cyclohexene, 90.0%, 250mg

methyl DL-3-amino-3-pyridin-3-ylpropanoate hydrochloride, 1g

Ethanol, 2-[[9-methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-, 250mg

Butyl Acetoacetate>98.0%(GC)25mL

S-(2-(N-((4-Amino-2-methylpyrimidin-5-yl)methyl)formamido)-5-(phosphonooxy)pent-2-en-3-yl)benzothioa, 95.0%, 100g

methyl({[6-(trifluoromethyl)pyridin-3-yl]methyl})amine dihydrochloride, 1g

2-Methoxy-5-aminobenzonitrile, 95.0%, 5g

4-Chloro-7-azaindole, 98.0%, 10g

Ethyl 5-chloro-2-methoxybenzoate, 5g

THIOMORPHOLINE-2-CARBOXYLIC ACID HCL, 95.0%, 1g

1-Methyl-1-propylpyrrolidin-1-ium Bromide>98.0%(T)5g

Narrow mouth bottle GL 45, 250 ml, 1 Piece